Go Pro
→ Do this before December or regret it (From Porter & Company) (Ad)tc pixel Free ARQT Stock Alerts

Arcutis Biotherapeutics (ARQT) Short Interest Ratio & Short Volume

Arcutis Biotherapeutics logo
$27.35 +0.02 (+0.07%)
Closing price 04:00 PM Eastern
Extended Trading
$27.40 +0.05 (+0.18%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Arcutis Biotherapeutics Short Interest Overview

As of July 15, 2026, Arcutis Biotherapeutics (ARQT) had a short interest of 13.56 million shares sold short, representing 11.97% of the public float. This marks a -3.26% decrease in short interest since the prior report. The short interest ratio (days to cover) is 9.3, meaning it would take 9.3 days of the average trading volume of 1.43 million shares to cover all short positions.

Current Short Interest
13,561,565 shares
Previous Short Interest
14,019,289 shares
Change Vs. Previous Month
-3.26%
Dollar Volume Sold Short
$376.74 million
Short Interest Ratio
9.3 Days to Cover
Last Record Date
July 15, 2026
Outstanding Shares
125,080,000 shares
Short Percent of Float
11.97%
Today's Trading Volume
819,320 shares
Average Trading Volume
1,429,169 shares
Today's Volume Vs. Average
57%
Short Selling Arcutis Biotherapeutics?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Arcutis Biotherapeutics and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

ARQT Short Interest Over Time

ARQT Days to Cover Over Time

ARQT Percentage of Float Shorted Over Time

Arcutis Biotherapeutics Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/202613,561,565 shares $376.74 million -3.3%12.0%9.34 $27.78
6/30/202614,019,289 shares $367.64 million -11.4%12.4%6.33 $26.22
6/15/202615,820,721 shares $404.69 million -2.5%14.0%10.04 $25.58
5/29/202616,226,183 shares $348.21 million -7.5%14.3%8.44 $21.46
5/15/202617,547,517 shares $374.11 million +4.0%15.5%7.3 $21.32
4/30/202616,879,909 shares $391.95 million +1.8%14.9%16.62 $23.22
4/15/202616,583,496 shares $407.62 million -1.3%14.6%15.62 $24.58
3/31/202616,801,149 shares $395.84 million +6.7%14.8%11.11 $23.56
3/13/202615,753,892 shares $358.40 million +3.0%14.0%12.56 $22.75
2/27/202615,292,517 shares $412.44 million -6.6%13.5%9.73 $26.97
2/13/202616,379,683 shares $423.58 million +2.3%14.5%14.06 $25.86
1/30/202616,010,858 shares $406.20 million +5.2%14.4%13.88 $25.37
1/15/202615,221,587 shares $401.24 million +1.4%13.7%8.41 $26.36
12/31/202515,011,554 shares $435.94 million +13.4%13.5%7.86 $29.04
12/15/202513,235,954 shares $383.18 million +9.8%11.9%6.78 $28.95
11/28/202512,059,791 shares $367.46 million -12.1%10.9%4.34 $30.47
11/14/202513,717,750 shares $342.94 million +1.8%12.4%5.45 $25.00
10/31/202513,479,227 shares $341.16 million -5.6%12.1%4.79 $25.31
10/15/202514,280,000 shares $308.88 million -1.2%13.1%8 $21.63
9/30/202514,450,000 shares $272.38 million -10.0%N/A8.1 $18.85
9/15/202516,050,000 shares $271.73 million -5.7%N/A9.5 $16.93
8/31/202517,020,000 shares $264.15 million -7.5%15.7%9.6 $15.52
8/15/202518,400,000 shares $310.78 million +10.6%N/A10.3 $16.89
7/31/202516,640,000 shares $242.61 million -3.7%15.3%8.9 $14.58
7/15/202517,270,000 shares $265.96 million -16.2%N/A9.1 $15.40
6/30/202520,600,000 shares $288.81 million +10.5%19.1%9.9 $14.02
6/15/202518,640,000 shares $250.34 million +11.1%17.3%8.5 $13.43
5/31/202516,780,000 shares $219.65 million +4.6%15.8%7.3 $13.09
5/15/202516,040,000 shares $218.63 million +5.9%15.1%6.6 $13.63
4/30/202515,140,000 shares $225.74 million +5.3%N/A6 $14.91
4/15/202514,380,000 shares $189.67 million -1.7%13.6%5.8 $13.19
3/31/202514,630,000 shares $228.81 million -3.2%13.8%6 $15.64
3/15/202515,110,000 shares $220.91 million -23.6%14.3%6.4 $14.62
2/28/202519,770,000 shares $270.65 million +12.1%18.7%9 $13.69
2/15/202517,640,000 shares $225.44 million -6.7%16.7%8.3 $12.78
1/31/202518,910,000 shares $250.37 million -6.5%N/A8.9 $13.24
1/15/202520,220,000 shares $281.46 million -3.6%N/A9.5 $13.92
12/31/202420,970,000 shares $292.11 million -9.3%N/A10.2 $13.93
12/15/202423,110,000 shares $293.27 million -1.8%N/A11.2 $12.69
11/30/202423,530,000 shares $306.83 million -6.0%N/A11.8 $13.04
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it? (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
11/15/202425,020,000 shares $231.69 million -9.9%N/A12.8 $9.26
10/31/202427,760,000 shares $230.69 million -1.1%N/A13.1 $8.31
10/15/202428,060,000 shares $262.36 million +3.4%N/A13.7 $9.35
9/30/202427,130,000 shares $252.31 million +9.1%N/A12.7 $9.30
9/15/202424,860,000 shares $265.01 million +0.7%N/A10.5 $10.66
8/31/202424,680,000 shares $268.52 million +3.7%N/A9.9 $10.88
8/15/202423,800,000 shares $202.30 million +8.4%N/A9 $8.50
7/31/202421,950,000 shares $221.04 million -3.1%N/A7.8 $10.07
7/15/202422,660,000 shares $244.05 million +6.2%N/A8 $10.77
6/30/202421,340,000 shares $198.46 million -18.0%N/A7 $9.30
6/15/202426,020,000 shares $224.55 million +5.6%N/A8.7 $8.63
5/31/202424,640,000 shares $205.99 million +11.1%N/A7.7 $8.36
5/15/202422,170,000 shares $204.85 million +2.2%N/A6 $9.24
4/30/202421,690,000 shares $180.46 million +10.3%N/A5.7 $8.32
4/15/202419,660,000 shares $198.37 million +2.1%N/A4.3 $10.09
3/31/202419,260,000 shares $190.87 million +28.5%N/A4 $9.91
3/15/202414,990,000 shares $159.79 million -5.0%N/A2.8 $10.66
2/29/202415,780,000 shares $162.22 million -6.9%N/A2.6 $10.28
2/15/202416,940,000 shares $135.01 million +1.0%N/A2.9 $7.97
1/31/202416,780,000 shares $98.50 million -19.4%N/A3.1 $5.87
1/15/202420,830,000 shares $75.82 million +3.2%N/A4.1 $3.64
12/31/202320,180,000 shares $65.18 million +3.7%N/A4.2 $3.23
12/15/202319,460,000 shares $47.48 million -6.9%N/A4.8 $2.44
11/30/202320,900,000 shares $38.46 million +19.4%N/A8.2 $1.84
11/15/202317,510,000 shares $36.42 million +2.6%N/A8 $2.08
10/31/202317,070,000 shares $38.41 million +21.4%N/A8.5 $2.25
10/15/202314,060,000 shares $54.55 million +8.3%N/A8.7 $3.88
9/30/202312,980,000 shares $68.92 million -2.3%29.0%12.1 $5.31
9/15/202313,280,000 shares $90.44 million +6.4%29.7%13.1 $6.81
8/31/202312,480,000 shares $106.58 million -19.2%27.9%11.3 $8.54
8/15/202315,450,000 shares $130.86 million +1.6%34.5%12.8 $8.47
7/31/202315,210,000 shares $165.94 million +3.1%33.9%12.3 $10.91
7/15/202314,760,000 shares $139.33 million +0.2%32.8%11.9 $9.44
6/30/202314,730,000 shares $140.38 million +12.5%32.8%11.3 $9.53
6/15/202313,090,000 shares $133.78 million +0.4%29.1%10 $10.22
5/31/202313,040,000 shares $97.93 million -13.1%29.1%10.3 $7.51
5/15/202315,010,000 shares $154.60 million -2.5%33.7%13.1 $10.30
4/30/202315,390,000 shares $213.00 million +0.3%35.2%15.6 $13.84
4/15/202315,350,000 shares $213.21 million +1.5%35.1%15.5 $13.89
3/31/202315,120,000 shares $166.32 million +10.0%34.5%15.4 $11.00
3/15/202313,750,000 shares $152.76 million +11.1%31.4%14.9 $11.11
2/28/202312,380,000 shares $200.31 million +4.2%28.2%15 $16.18
2/15/202311,880,000 shares $203.62 million +10.1%27.2%15 $17.14
1/31/202310,790,000 shares $178.79 million +0.5%25.0%13 $16.57
1/15/202310,740,000 shares $151.65 million +0.9%24.9%13.1 $14.12
12/30/202210,650,000 shares $157.62 million +6.8%24.7%13.9 $14.80
12/15/20229,970,000 shares $164.41 million +5.1%23.1%12.7 $16.49
11/30/20229,490,000 shares $163.51 million +17.9%22.0%12.6 $17.23
11/15/20228,050,000 shares $156.49 million +0.1%18.7%10.8 $19.44
10/31/20228,040,000 shares $142.15 million +17.4%19.2%12.1 $17.68
Have you seen Elon’s new “supercurrency”? (It affects you) (Ad)

Elon Musk just became the world's first trillionaire following the biggest IPO in history, giving him access to what millionaire trader Tim Bohen calls a rare supercurrency. Tim believes this shift could ripple into a handful of small, overlooked stocks in the coming weeks.tc pixel

Watch Tim's free video breakdown before this story develops further
10/15/20226,850,000 shares $127.68 million +14.4%16.4%9.1 $18.64
9/30/20225,990,000 shares $114.47 million +15.2%14.3%8.6 $19.11
9/15/20225,200,000 shares $97.19 million +1.6%12.5%7.7 $18.69
8/31/20225,120,000 shares $137.98 million -1.7%12.4%8.4 $26.95
8/15/20225,210,000 shares $128.79 million +13.8%12.9%9 $24.72
7/31/20224,580,000 shares $111.11 million +16.8%12.6%8.2 $24.26
7/15/20223,920,000 shares $94.86 million +12.3%12.6%9.5 $24.20
6/30/20223,490,000 shares $74.37 million +5.8%11.3%8.6 $21.31
6/15/20223,300,000 shares $67.82 million +6.8%10.5%8.6 $20.55
5/31/20223,090,000 shares $64.52 million +6.2%9.8%8.8 $20.88
5/15/20222,910,000 shares $52.18 million -1.4%9.5%9.8 $17.93
4/30/20222,950,000 shares $59.56 million +3.2%9.6%10.5 $20.19
4/15/20222,860,000 shares $60.15 million -15.4%9.5%10.3 $21.03
3/31/20223,380,000 shares $65.10 million -9.1%12.1%12.5 $19.26
3/15/20223,720,000 shares $59.45 million +15.9%13.3%15.9 $15.98
2/28/20223,210,000 shares $57.14 million +3.2%11.4%15.8 $17.80
2/15/20223,110,000 shares $51.32 million +6.9%11.1%14.4 $16.50
1/31/20222,910,000 shares $43.97 million +26.0%10.6%14.5 $15.11
1/15/20222,310,000 shares $40.22 million +9.0%8.4%12.4 $17.41
12/31/20212,120,000 shares $43.97 million +7.1%7.7%12.7 $20.74
12/15/20211,980,000 shares $31.68 million No Change7.2%11.7 $16.00
11/30/20211,980,000 shares $32.81 million -1.0%7.2%12.1 $16.57
11/15/20212,000,000 shares $40.50 million +0.5%7.3%13.3 $20.25
10/29/20211,990,000 shares $42.15 million +1.0%7.2%14 $21.18
10/15/20211,970,000 shares $43.89 million -0.5%7.2%12.7 $22.28
9/30/20211,980,000 shares $47.30 million -4.4%7.2%12.1 $23.89
9/15/20212,070,000 shares $45.08 million -5.5%7.5%11.6 $21.78
8/31/20212,190,000 shares $46.36 million -4.0%8.0%12.6 $21.17
8/13/20212,280,000 shares $46.69 million -1.3%8.3%13.2 $20.48
7/30/20212,310,000 shares $53.89 million +2.2%8.5%11.3 $23.33

ARQT Short Interest - Frequently Asked Questions

Short interest is the volume of Arcutis Biotherapeutics shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 14,019,289 shares of ARQT short. 12.37% of Arcutis Biotherapeutics' shares are currently sold short. Learn More on Arcutis Biotherapeutics' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ARQT shares currently have a short interest ratio of 6.3. Learn More on Arcutis Biotherapeutics's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.37% of Arcutis Biotherapeutics' floating shares are currently sold short.

Arcutis Biotherapeutics saw a decrease in short interest in June. As of June 30th, there was short interest totaling 14,019,289 shares, a decrease of 11.4% from the previous total of 15,820,721 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

12.37% of Arcutis Biotherapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Arcutis Biotherapeutics: Elanco Animal Health Incorporated (7.13%), Axsome Therapeutics, Inc. (6.45%), Summit Therapeutics PLC (31.12%), Abivax SA Sponsored ADR (5.42%), Dr. Reddy's Laboratories Ltd (2.83%), Cytokinetics, Incorporated (14.50%), Arrowhead Pharmaceuticals, Inc. (6.21%), Krystal Biotech, Inc. (13.73%), Nuvalent, Inc. (3.88%), Kymera Therapeutics, Inc. (14.68%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($82.01 billion), Invesco QQQ ($47.15 billion), iShares Russell 2000 ETF ($24.07 billion), Nebius Group N.V. ($16.85 billion), Western Digital Corporation ($14.29 billion), SPDR S&P Biotech ETF ($11.89 billion), VanEck Semiconductor ETF ($11.29 billion), KLA Corporation ($10.37 billion), iShares 20+ Year Treasury Bond ETF ($8.78 billion), and Lumentum Holdings Inc. ($8.29 billion). View all of the most shorted stocks.

Short selling ARQT is an investing strategy that aims to generate trading profit from Arcutis Biotherapeutics as its price is falling. ARQT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Arcutis Biotherapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ARQT, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ARQT, twice per month. The most recent reporting period available is June, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like ARQT:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NASDAQ:ARQT) was last updated on 7/24/2026 by MarketBeat.com Staff.
From Our Partners
Elon says “don’t save money.” Is he right?
Robert Kiyosaki, author of Rich Dad Poor Dad, says you don't have to wait for Elon Musk's vision of universal ...
Freedom Financial | Sponsoredtc pixel
The number they’re trying to hide from you
The 10-year Treasury yield is nearing 4.4 percent, a level analyst Garrett Goggin says could force the Federal...
Golden Portfolio | Sponsoredtc pixel
Have you seen Elon’s new “supercurrency”? (It affects you)
Elon Musk just became the world's first trillionaire following the biggest IPO in history, giving him access t...
StocksToTrade | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Two states are racing to block Elon Musk’s new money
New York and Massachusetts are racing to block Elon Musk's newest project, with Senator Elizabeth Warren fight...
Banyan Hill Publishing | Sponsoredtc pixel
Elon did WHAT?!
Something big is happening beyond SpaceX. Accelerated AI stocks have surged 133%, 217%, and even 320% in just ...
Brownstone Research | Sponsoredtc pixel
The market told you. In writing. Early.
Some trading losses are surprises. Others are scheduled months, even a year, in advance and published for free...
Profits Run | Sponsoredtc pixel